×
Hero Background

ADHD Therapeutics Companies

ID: MRFR/HC/1044-HCR
200 Pages
Rahul Gotadki
October 2025

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent patterns of inattention, hyperactivity, and impulsivity. The treatment of ADHD often involves a combination of behavioral interventions, psychoeducation, and pharmacotherapy. Several pharmaceutical companies are involved in the development and production of medications used in the management of ADHD symptoms.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

ADHD Therapeutics Market Research Report - Forecast till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the ADHD Therapeutics Market

ADHD Therapeutics Companies

 


Latest ADHD Therapeutics Companies Updates:


This US-based company is preparing to submit a New Drug Application (NDA) for its once-daily ADHD medication, CTx-1301, by mid-2024.CTx-1301 uses Cingulate's innovative Precision Timed Release (PTR) technology to deliver three timed doses of dexmethylphenidate throughout the day, potentially improving patient adherence and reducing side effects.Positive top-line results from Phase III trials in adults have already been announced, with pediatric and adolescent trials slated for August 2023.


ABVC, a clinical-stage biopharmaceutical company, secured a US patent for the use of PDC-1421, a Radix Polygala extract, in its ADHD drug ABV-1505.ABV-1505 acts as a Norepinephrine Transporter (NET) inhibitor, a novel approach to treating ADHD with fewer side effects than traditional stimulants.Phase IIa trials have shown promise, with Phase IIb results expected by year-end, potentially positioning ABVC for a unique entry into the market.


List of ADHD Therapeutics Key companies in the market:



  • Advanz Pharmaceutical (Canada)

  • Eli Lilly and Company (US)

  • Highland Therapeutics Inc. (Canada)

  • Janssen Pharmaceuticals, Inc. (Belgium)

  • NEOS Therapeutics, Inc. (US)

  • Pfizer Inc. (US)

  • Novartis AG (Switzerland)

  • Noven Pharmaceuticals, Inc. (US)